Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,002 public trials 569 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Active, Not Recruiting

Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM

NCT07084896

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • 238995 Atlanta, Georgia, United States
  • 240593 Boston, Massachusetts, United States
  • 251164 Grand Rapids, Michigan, United States
  • 239015 Madison, Wisconsin, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

A Study of AT-02 in Subjects With Systemic Amyloidosis.

NCT05951049

Conditions
Amyloidosis, Amyloidosis; Systemic, Immune System Diseases, +10 more
Locations
  • Kansas City Kansas City, Kansas, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • OHSU (Oregon Health & Science University) Portland, Oregon, United States
  • Penn Presbyterian Medical Center Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

NCT04126200

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • GSK Investigational Site Atlanta, Georgia, United States
  • GSK Investigational Site Indianapolis, Indiana, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Grand Rapids, Michigan, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

NCT03319667

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Investigational Site Number: 8400006 Fort Myers, Florida, United States
  • Investigational Site Number: 8400004 St. Petersburg, Florida, United States
  • Investigational Site Number: 8400007 Kansas City, Missouri, United States
  • Investigational Site Number: 8400005 Nashville, Tennessee, United States
View all 104 locations
View Trial Details

Related conditions